ArticleBMC cancer2025
Association between triglyceride-glucose index and hypertension in adults with cancer from NHANES 2005-2018: a cross-sectional study.
Article in BMC cancer, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundInsulin resistance (IR) is linked to hypertension development.The triglyceride-glucose (TyG) index is a proposed alternative biochemical marker for IR. This study aimed to explore the relationship between TyG and hypertension in adults with cancer.
methodsA cross-sectional study was conducted involving 1,222 cancer adults patients from the NHANES dataset (2005-2018). Demographics, medical history, lifestyle factors, and lab tests were assessed. Multivariable logistic regression, subgroup analysis, and smooth curve-fitting techniques were used.
resultsAmong 1,222 eligible participants, 775 (56.29%) had hypertension. When TyG was assessed as a continuous variable, higher TyG levels were significantly associated with increased hypertension prevalence (OR, 1.51; 95% CI, 1.09-2.11; p = 0.015) after adjusting for covariates. When TyG was analyzed as quartiles, compared to individuals with lower TyG Q1 (7.0-8.3), the adjusted OR values for TyG and hypertension in Q2 (8.3-8.7), Q3 (8.7-9.1), and Q4 (9.1-10.7) were 1.32 (95% CI: 0.85-2.06, p = 0.022), 1.63 (95% CI: 1.01-2.64, p = 0.043), and 1.68 (95% CI: 1.09-2.84, p = 0.041), respectively. The data were stratified by age, sex, marital status, education level, and family income. Stratified analysis revealed no significant interactions among subgroups (all p-Values > 0.05). Analysis using restricted cubic splines(RCS) suggested a linear relationship between TyG and hypertension in adults with cancer.
conclusionsHigher TyG levels are associated with an increased risk of hypertension in adults with cancer.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.